Patricia Jauregui
Pamplona, NC 31008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreatic cancer.
Journal: Gene therapy
Published: April 02, 2025
Neuropilin-2 upregulation by stromal TGFβ1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth.
Journal: Neoplasia (New York, N.Y.)
Published: February 06, 2025
Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML.
Journal: Molecular therapy. Oncology
Published: October 15, 2024
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.
Journal: Frontiers in immunology
Published: August 01, 2023
Correction to: Effect of a Diet Supplemented with Sphingomyelin and Probiotics on Colon Cancer Development in Mice.
Journal: Probiotics and antimicrobial proteins
Published: November 04, 2022
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome.
Journal: Science advances
Published: September 30, 2022
Effect of a Diet Supplemented with Sphingomyelin and Probiotics on Colon Cancer Development in Mice.
Effect of a Diet Supplemented with Sphingomyelin and Probiotics on Colon Cancer Development in Mice.
Journal: Probiotics and antimicrobial proteins
Published: January 19, 2022
CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation.
Journal: Nature communications
Published: October 13, 2020
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.
Journal: International journal of cancer
Published: May 14, 2019
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 26, 2019
Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer.
Journal: Cancer letters
Published: January 18, 2018
Last Updated: 09/26/2026